Cytely
PrivateLast Round
Seed
Oct 22, 2025
Total Funding Raised
$3.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cytely operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was a Seed round in October 2025.
Cytely is a life sciences tool company that provides a smart microscopy software platform to automate real-time analysis and data capture for biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytely Comparables
Compare Cytely with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dassault Systèmes | 73% | |
| Veeva Systems | 67% | |
| Biodock | 44% |
For institutional investors. Book with your work email.
Cytely Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cytely Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ugly Duckling Ventures | Seed |
| Icebreaker.vc | Seed, Pre Seed |
| SmiLe Venture Hub | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 228% MoM, reaching 2.8K.
- Aug 22, 2026
Monthly visitors grew 368% MoM, from 180 to 842.
For institutional investors. Book with your work email.
Cytely Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytely's valuation, stock price, and market status.
Is Cytely a public or private company?
Cytely is a private company.
What is the current stock price of Cytely?
Cytely is a private company, so its shares have no public market price. Caplight tracks Cytely's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytely worth (valuation)?
Valuation information for Cytely is not publicly available.
Can I buy Cytely stock?
Cytely shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytely's last funding round?
Cytely's most recent funding round was Seed on October 22, 2025.
Who are the main investors in Cytely?
Key investors in Cytely include Ugly Duckling Ventures.
Will Cytely IPO soon?
No public IPO plans have been announced for Cytely.
How can I track Cytely secondary market activity?
Caplight tracks bids, offers, and trades in Cytely's shares on secondary markets.